Catalyst Pharmaceuticals Earning Date (CPRX)

USA |NASDAQ |USD

CPRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 14, 2022 Dec 2021 $0.11 $0.10 $0.11
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 14, 2022 Dec 2021 $36.90M $35.95M $31.01M

Catalyst Pharmaceuticals's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 2021.

CPRX Earnings Date & History Chart

CPRX Earnings & Revenue Forecast

CPRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $0.11 $0.10 $0.12
Mar 2022 3 $0.11 $0.10 $0.12
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $0.39 $0.38 $0.41
Dec 2022 5 $0.50 $0.44 $0.61

CPRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 1 $0.11 $0.11 $0.09
Mar 2022 0 / 1 $0.16 $0.16 $0.12
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 1 $0.39 $0.39 $0.39
Dec 2022 2 / 1 $0.56 $0.55 $0.43

CPRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $36.90M $36.25M $37.91M
Mar 2022 3 $38.26M $38.00M $38.66M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $137.74M $135.98M $139.38M
Dec 2022 5 $164.18M $156.25M $175.71M

CPRX Earnings Date & Revenue History

CPRX Earnings History

|
Show More
Show More

CPRX Revenue History

|
Show More
Show More

Catalyst Pharmaceuticals Next Earnings Date & Report

CPRX Next Earnings Date & Report Preview: Dec 2021 (FQ)

CPRX's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 5 analysts, the average EPS estimation for Catalyst Pharmaceuticals's next quarterly earnings is $0.11, with a low EPS estimation of $0.10, and a high estimation of $0.12.

Over the last 1 month, EPS estimates have seen 3 upward revisions and 1 downward. The EPS 1 month trend is $0.11, the last 2 month trend is $0.11, and the 3 month trend is $0.09.

Based on 5 analysts, the average revenue estimation is $36.90M, with a low revenue estimation of $36.25M, and a high estimation of $37.91M.

Catalyst Pharmaceuticals Previous Earnings Dates & Reports

CPRX Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Catalyst Pharmaceuticals's previous earnings date was Nov 9, 2021 for its fiscal quarter ended Sep 30, 2021.

CPRX's earnings per share (EPS) was $0.10, missing the consensus analysts forecast of $0.10 by -3.85%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by -9.09%, and lower than the same period a year before (Sep 2020) by -75.61%.

Revenues were $35.95M, better than the forecast of $34.59M by 3.94%, down by -1.13% from the previous quarter , and up by 22.64% from the same period last year.

The company reported a net income of $10.33M, -15.20% lower than the previous quarter, and lower by -76.17% than the same period a year before.

Free cash flow for the quarter was $21.64M , compared to $15.67M last quarter and $11.44M a year before.

CPRX ended the quarter with $7.95M in total debt, an increase of 86.92% compared to the previous quarter, and an increase of 6835.92% compared to the same quarter a year before.

CPRX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Catalyst Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

CPRX's earnings per share (EPS) was $0.71, beating the consensus analysts forecast of $0.69 by 2.90% , and higher than the previous year's EPS (Dec 2019) by 144.83%.

Revenues were $119.07M, better than the forecast of $118.35M by 0.61%, and up by 16.39% from previous year's revenue.

The company reported a net income of $74.98M, 135.24% higher than the previous year.

Catalyst Pharmaceuticals reported a free cash flow of $45.02M for its fiscal year, compared to $34.59M a year ago.

The company ended the fiscal year with $28.77K in total debt, a decrease of -96.97% compared to the previous year.